MRI-US Fusion for Uterine Cancer Treatment

Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking

Recruiting Observational Study
Uterine Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Female
Study type
Observational
Participants needed
17 (estimated)
Sponsor
Duke University · Other
Who this trial is looking for

This trial is looking for adult women with certain types of uterine cancer. Participants will help test a new imaging technique for guiding needle treatments.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with invasive uterine cancer
  • I am at least 18 years old
  • I can receive treatment aimed at curing my cancer
  • I am feeling well enough to participate in the trial

You may not be able to join if

  • I have active rectal bleeding
  • I have a rectal ulcer

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to utilize transrectal ultrasound (TRUS) images of the intact and post-hysterectomy female pelvis in order to provide feasibility information for a Magnetic Resonance Imaging (MRI)-TRUS fusion based 3D needle navigation system for use in image guided brachytherapy. The fusion and needle guidance will be performed using Eigen Health's navigation system that currently pr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histologically proven invasive primary squamous, adenosquamous, or adenocarcinoma of the uterine cervix, (recurrent or medically inoperable) uterine adenocarcinoma. * Treatment plan must include curative-intent definitive radiation that includes brachytherapy treatments with o…
Contacts

Kaitlin Bailey, BNS RN

(919) 668-3726

Kaitlin.Bailey@duke.edu

CONTACT